Enhanced efficacy and reduced side effects of diazepam by kava combination.

Tawfiq, Rasha A; Nassar, Noha N; El-Eraky, Wafaa I; El-Denshary, Ezzeldein S

Tawfiq, Rasha A; Nassar, Noha N; El-Eraky, Wafaa I; El-Denshary, Ezzeldein S.

Afiliação

Tawfiq RA; Egyptian Patent Office, Academy of Scientific Research and Technology, 101 Kasr El-Eini St., Cairo, Egypt.
Nassar NN; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Eini St., Cairo, Egypt.
El-Eraky WI; Department of Pharmacology, National Research Center, El-Tahrir St., Giza, Egypt.
El-Denshary ES; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Eini St., Cairo, Egypt.

J Adv Res ; 5(5): 587-94, 2014 Sep.

Article em En | MEDLINE | ID: mdl-25685527

Palavras-chave

AED, antiepileptic drug; ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; Anticonvulsant; BDZ, benzodiazepine; DZ, diazepam; Diazepam; ECT, electroconvulsive treatment; FDA, Food and Drug Administration; GABA, Î³-aminobutyric acid; GABAA, Î³-aminobutyric acid type A; Kava; Locomotor activity; MEST; MEST, maximal electroshock threshold; OTC, over the counter; WHO, World Health Organization

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Idioma: En Revista: J Adv Res Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google